Laura S. Schmidt

58.3k total citations · 2 hit papers
101 papers, 9.1k citations indexed

About

Laura S. Schmidt is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Laura S. Schmidt has authored 101 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 45 papers in Pulmonary and Respiratory Medicine and 22 papers in Genetics. Recurrent topics in Laura S. Schmidt's work include Renal cell carcinoma treatment (42 papers), Renal and related cancers (37 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Laura S. Schmidt is often cited by papers focused on Renal cell carcinoma treatment (42 papers), Renal and related cancers (37 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Laura S. Schmidt collaborates with scholars based in United States, Germany and Japan. Laura S. Schmidt's co-authors include W. Marston Linehan, Berton Zbar, Ramaprasad Srinivasan, Maria J. Merino, Peter L. Choyke, G.M. Glenn, McClellan M. Walther, Gregor Weirich, Jorge R. Toro and Michael L. Nickerson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Laura S. Schmidt

97 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome

2002 638 citations Michael L. Nickerson, Michelle B. Warren et al. Cancer Cell profile →
The genetic basis of kidney cancer: a metabolic disease

2010 550 citations W. Marston Linehan, Laura S. Schmidt et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura S. Schmidt United States	46	6.0k	5.0k	2.0k	1.6k	1.5k	101	9.1k
Michael I. Lerman United States	61	10.2k 1.7×	2.9k 0.6×	4.3k 2.1×	1.6k 1.0×	1.5k 1.0×	165	14.5k
Maria Tretiakova United States	54	4.5k 0.7×	3.4k 0.7×	2.1k 1.0×	731 0.4×	293 0.2×	177	10.4k
Kenneth J. Hillan United States	36	9.0k 1.5×	2.5k 0.5×	3.0k 1.5×	755 0.5×	346 0.2×	57	14.6k
Zhengping Zhuang United States	63	4.9k 0.8×	1.5k 0.3×	4.0k 2.0×	831 0.5×	623 0.4×	321	12.3k
Michael A. Tainsky United States	47	7.8k 1.3×	1.1k 0.2×	2.5k 1.3×	1.9k 1.1×	727 0.5×	156	12.5k
Reinhard Buettner Germany	60	8.9k 1.5×	2.3k 0.5×	2.1k 1.0×	1.6k 0.9×	383 0.3×	312	14.3k
Garrett M. Frampton United States	55	8.2k 1.4×	3.7k 0.7×	4.0k 2.0×	1.2k 0.7×	530 0.4×	219	15.6k
Donald P. Bottaro United States	54	8.0k 1.3×	1.8k 0.4×	1.4k 0.7×	882 0.5×	316 0.2×	165	12.5k
Raymond S. Yeung United States	45	3.2k 0.5×	872 0.2×	844 0.4×	639 0.4×	2.5k 1.7×	131	6.6k
Yoshitaka Sekido Japan	69	9.3k 1.6×	3.6k 0.7×	3.3k 1.6×	942 0.6×	228 0.2×	199	14.3k

Countries citing papers authored by Laura S. Schmidt

Since Specialization

Citations

This map shows the geographic impact of Laura S. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura S. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura S. Schmidt more than expected).

Fields of papers citing papers by Laura S. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura S. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura S. Schmidt. The network helps show where Laura S. Schmidt may publish in the future.

Co-authorship network of co-authors of Laura S. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Laura S. Schmidt. A scholar is included among the top collaborators of Laura S. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura S. Schmidt. Laura S. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Huili, Ana Teresa Amaral, Thiago Vidotto, et al.. (2025). mTOR ‐mediated upregulation of B7 ‐ H3 in MiT / TFE translocation renal cell carcinoma. The Journal of Pathology. 268(1). 77–88.

Zhang, Xian, Shun Li, H. Mytrang, et al.. (2023). Reprogramming tumour-associated macrophages to outcompete cancer cells. Nature. 619(7970). 616–623. 77 indexed citations

Lang, Martin, Cathy D. Vocke, Christopher J. Ricketts, et al.. (2020). Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma. Urology. 149. 89–97. 25 indexed citations

Menko, Fred H., Eamonn R. Maher, Laura S. Schmidt, et al.. (2014). Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Familial Cancer. 13(4). 637–644. 195 indexed citations

Schmidt, Laura S. & W. Marston Linehan. (2014). Clinical features, genetics and potential therapeutic approaches for Birt–Hogg–Dubé syndrome. Expert Opinion on Orphan Drugs. 3(1). 15–29. 30 indexed citations

Schmidt, Laura S., Jessica L. Mester, Samuel Peña‐Llopis, et al.. (2013). A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma. Molecular Cancer Research. 11(9). 1061–1071. 113 indexed citations

Schindler, Stephanie, Peter Schönknecht, Laura S. Schmidt, et al.. (2013). Development and Evaluation of an Algorithm for the Computer-Assisted Segmentation of the Human Hypothalamus on 7-Tesla Magnetic Resonance Images. PLoS ONE. 8(7). e66394–e66394. 35 indexed citations

Schmidt, Laura S.. (2012). Birt–Hogg–Dubé syndrome: from gene discovery to molecularly targeted therapies. Familial Cancer. 12(3). 357–364. 32 indexed citations

Toro, Jorge R., G.M. Glenn, Michael Weinreich, et al.. (2008). BHD mutations, clinical and molecular genetic investigations of Birt–Hogg–Dubé syndrome: a new series of 50 families and a review of published reports. Journal of Medical Genetics. 45(6). 321–331. 333 indexed citations

10.

Toro, Jorge R., Stephen E. Pautler, Laveta Stewart, et al.. (2007). Lung Cysts, Spontaneous Pneumothorax, and Genetic Associations in 89 Families with Birt-Hogg-Dubé Syndrome. American Journal of Respiratory and Critical Care Medicine. 175(10). 1044–1053. 232 indexed citations

11.

Singh, Shree Ram, Zhen Wei, Zhi‐Ming Zheng, et al.. (2006). The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance. Oncogene. 25(44). 5933–5941. 46 indexed citations

12.

Coveney, Douglas, Xiaoning Peng, Chitralekha Bhattacharya, et al.. (2005). The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature. 435(7040). 360–364. 288 indexed citations

13.

Vocke, Cathy D., Youfeng Yang, Christian P. Pavlovich, et al.. (2005). High Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dubé–Associated Renal Tumors. JNCI Journal of the National Cancer Institute. 97(12). 931–935. 173 indexed citations

14.

Nickerson, Michael L., Michelle B. Warren, Jorge R. Toro, et al.. (2002). Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell. 2(2). 157–164. 638 indexed citations breakdown →

15.

Lee, Jae‐Ho, Hyeseong Cho, Barbara Jennings, et al.. (2000). A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene. 19(43). 4947–4953. 274 indexed citations

16.

Weirich, Gregor, Michael Sandherr, Christian Fellbaum, et al.. (1998). Molecular evidence of bone marrow involvement in advanced case of Tγδ lymphoma with secondary myelofibrosis. Human Pathology. 29(7). 761–765. 13 indexed citations

17.

Zhuang, Zhengping, Won-Sang Park, Svetlana Pack, et al.. (1998). Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas. Nature Genetics. 20(1). 66–69. 220 indexed citations

18.

Duh, Fuh-Mei, Stephen W. Scherer, Lap‐Chee Tsui, et al.. (1997). Gene structure of the human MET proto-oncogene. Oncogene. 15(13). 1583–1586. 46 indexed citations

19.

Gilcrease, Michael Z., Laura S. Schmidt, Berton Zbar, et al.. (1995). Somatic von hippel-lindau mutation in clear cell papillary cystadenoma of the epididymis. Human Pathology. 26(12). 1341–1346. 39 indexed citations

20.

Modi, W.S., Laura S. Schmidt, L. Geil, et al.. (1992). Molecular and genetic characterization and physical mapping of 11 new markers detecting multiallele restriction fragment length polymorphisms on the short arm of human chromosome 3. Human Genetics. 90(1-2). 17–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact